Sudden death during adjuvant trastuzumab therapy of breast cancer.
Oliveira
M
M
Medical Oncology Service, Instituto Português de Oncologia Francisco Gentil.
Nave
M
M
Medical Oncology Unit, Hospital da Luz, Lisboa, Portugal.
Gil
N
N
Medical Oncology Unit, Hospital da Luz, Lisboa, Portugal.
Passos-Coelho
J L
JL
Medical Oncology Service, Instituto Português de Oncologia Francisco Gentil; Medical Oncology Unit, Hospital da Luz, Lisboa, Portugal. Electronic address: jcoelho@hospitaldaluz.pt.
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000150:complications; D001943:Breast Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D002277:Carcinoma / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D003645:Death, Sudden; D005260:Female; D006801:Humans; D015412:Mastectomy, Segmental; D008875:Middle Aged; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068878:Trastuzumab